Sep 05 2022
Off

The additional data from the tocilizumab arm of the RECOVERY trial, the post hoc analysis of the CORIMUNO-19 TOCI-1 and the meta-analysis of RCTs published in the JAMA helped clarifying the scenario

By icmt24

The additional data from the tocilizumab arm of the RECOVERY trial, the post hoc analysis of the CORIMUNO-19 TOCI-1 and the meta-analysis of RCTs published in the JAMA helped clarifying the scenario. not mounting normal anti-SARS-CoV-2 antibody responses. Conclusion This new SLR confirms that some immunomodulators (tocilizumab and JAK inhibitors) have a role for treating…

Jun 25 2022
Off

Mice were immunized with ovalbumin (OVA) (20 g/mouse) and oligodeoxynucleotide (ODN) BL07S (1 g or 10 g/mouse) in alum at 2-week intervals

By icmt24

Mice were immunized with ovalbumin (OVA) (20 g/mouse) and oligodeoxynucleotide (ODN) BL07S (1 g or 10 g/mouse) in alum at 2-week intervals. dose-dependent. The present results demonstrate that ODN BL07S from genomic DNA of BB536 helps prevent antigen-induced Th2 immune reactions BB536, IgE, ISS-ODN, probiotics Intro Type I allergies such as allergic rhinitis and hay…